₹0.02
(Market cap
₹109 Cr
Recently Viewed
Clear AllMarket cap
₹109 Cr
Revenue (TTM)
₹25 Cr
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹-14 Cr
ROE
-20.6 %
ROCE
-17.7 %
Industry P/E
47.51
EV/EBITDA
-7.6
Debt to Equity
0.6
Book Value
₹14
EPS
₹-4.4
Face value
10
Shares outstanding
35,267,812
CFO
₹-29.20 Cr
EBITDA
₹-36.28 Cr
Net Profit
₹-33.48 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Pharmaids Pharma
| -35.0 | -3.2 | -29.9 | -53.5 | 7.3 | 13.5 | 19.5 |
|
BSE Healthcare
| 1.8 | 4.5 | 5.7 | 4.6 | 24.6 | 13.6 | 11.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Pharmaids Pharma
| -35.6 | 37.9 | 73.1 | 82.5 | -5.7 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Pharmaids Pharma
|
31.0 | 109.3 | 25.5 | -15.3 | -75.8 | -28.2 | -- | 2.2 |
| 2,386.7 | 19,539.0 | 1,215.1 | 284.8 | 28.7 | 21.1 | 68.1 | 12.9 | |
| 768.8 | 15,131.4 | 7,266.8 | 627.5 | 11.9 | 12.6 | 24.1 | 2.8 | |
| 363.9 | 13,919.7 | 2,051.5 | 180.5 | 11.6 | 7.7 | 69 | 3.6 | |
| 687.0 | 17,017.5 | 5,092.5 | 545.5 | 15.9 | 14.1 | 31.2 | 3.8 | |
| 1,071.5 | 19,182.7 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.3 | 2.2 | |
| 1,768.6 | 20,273.4 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1008.5 | 3.5 | |
| 163.9 | 21,773.1 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.7 | |
| 428.4 | 17,259.9 | 3,720.2 | 352.1 | 13.7 | 8.2 | 49 | 3.6 | |
| 1,441.1 | 23,406.2 | 3,151.0 | -10.0 | 8.4 | 2.5 | 1063.9 | 5.1 |
No Review & Analysis are available.
Wholesale of pharmaceutical and medical goods
Incorporated
1989
Chairman
--
Managing Director
--
Headquarters
Bengaluru, Karnataka
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
The share price of Pharmaids Pharmaceuticals Ltd is ₹31.00 (BSE) as of 23-Apr-2026 IST. Pharmaids Pharmaceuticals Ltd has given a return of 7.29% in the last 3 years.
Since, TTM earnings of Pharmaids Pharmaceuticals Ltd is negative, P/E ratio is not available.
The P/B ratio of Pharmaids Pharmaceuticals Ltd is 2.22 times as on 23-Apr-2026, a 33 discount to its peers’ median range of 3.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
4.08
|
|
2024
|
0.00
|
2.55
|
|
2023
|
0.00
|
2.13
|
|
2022
|
88.51
|
1.48
|
|
2021
|
122.99
|
1.35
|
The 52-week high and low of Pharmaids Pharmaceuticals Ltd are Rs 73.45 and Rs 27.10 as of 23-Apr-2026.
Pharmaids Pharmaceuticals Ltd has a market capitalisation of ₹ 109 Cr as on 23-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Pharmaids Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.